CELGENE CORPORATION : - U.S. FDA Approves INREBIC as First New Treatment in Nearly a Decade for Patients with Myelofibrosis

Press/Media: Press / Media

PeriodAug 19 2019

Media coverage

1

Media coverage

  • TitleCELGENE CORPORATION : - U.S. FDA Approves INREBIC as First New Treatment in Nearly a Decade for Patients with Myelofibrosis
    Media name/outletMarketScreener.com
    CountryUnited States
    Date8/19/19
    PersonsRuben Mesa